2-26402015-C-T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_145038.5(DRC1):c.26C>T(p.Ala9Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00035 in 1,610,364 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_145038.5 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 21Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- spermatogenic failure 80Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DRC1 | NM_145038.5 | c.26C>T | p.Ala9Val | missense_variant | Exon 1 of 17 | ENST00000288710.7 | NP_659475.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DRC1 | ENST00000288710.7 | c.26C>T | p.Ala9Val | missense_variant | Exon 1 of 17 | 2 | NM_145038.5 | ENSP00000288710.2 | ||
| DRC1 | ENST00000421869.5 | n.26C>T | non_coding_transcript_exon_variant | Exon 1 of 8 | 1 | ENSP00000414375.1 | ||||
| DRC1 | ENST00000649059.1 | n.11C>T | non_coding_transcript_exon_variant | Exon 1 of 16 | ENSP00000497543.1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152232Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000347 AC: 84AN: 241838 AF XY: 0.000411 show subpopulations
GnomAD4 exome AF: 0.000363 AC: 529AN: 1458014Hom.: 0 Cov.: 30 AF XY: 0.000389 AC XY: 282AN XY: 724864 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000230 AC: 35AN: 152350Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74500 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Primary ciliary dyskinesia Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 9 of the DRC1 protein (p.Ala9Val). This variant is present in population databases (rs146049908, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with DRC1-related conditions. ClinVar contains an entry for this variant (Variation ID: 571634). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at